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Background
MCF-7 human breast cancer cells are well-studied and used in
research for the generation of new and reputable knowledge. In
previous studies, MCF-7 cancer cells with overexpressed matrix
metalloproteinases (MMPs) were linked to tumor progression, as
MMPs are involved in cell growth and invasion (Nazir et al.,
2019). Ideally, cancer cells are more resistant to cell death
(apoptosis) and follow a regulated pathway to resist death.
Interestingly, this sparked the interest to investigate whether
overexpressed MMP14 (a member of the matrix
metalloproteinase family) would have the ability to induce cell
death in human breast cancer cells.
Using Cells with Varying MMP14 Expression
In the Damjanovoski lab, parental MCF-7 were used to create new
cells with varying levels of MMP14. When compared to MCF-7
parental cells, the C3 cell lines express low levels of MMP14 (~11
fold), followed by ΔCD cell lines expressing more MMP14 (~100
fold), and the C2 cell lines with the most MMP14 expression
(~500 fold) (Figure 1). MMP14 is found on the cell-surface and
has many domains that can bind to other proteins, one of which is
FIH-1.

Figure 1. Different expression levels of cell surface matrix
metalloproteinase (MMP14) in different cell lines (C3, ΔCD, and
C2). ΔCD cells do not have a tail that is found on the cytosolic
side of the cell.

How MMP14 Expression Effects Apoptotic Sensitivity
With the engineered MCF-7 cells that express greater MMP14 (C2
and ΔCD), they are more sensitive to apoptosis. Since there is
more MMP14, most of the FIH-1 will be bound to MMP14 as
opposed to BAX; therefore, the cell is susceptible to death.
However, with cells that have less MMP14, most of the FIH-1
would be bound to BAX and is less likely to undergo apoptosis.

Important Players of the Apoptotic Pathway
In the apoptotic pathway, the two key players that were of focus for
this study were BAX and FIH-1. Both of these molecules are
important in regulating the apoptotic pathway. FIH-1 roams freely in
the cell, whereas BAX is found within the mitochondria. FIH-1 can
bind to BAX. When bound, the cell will turn off the apoptotic
pathway; thus, promoting survival (Yan et al., 2011). However, FIH1 also has the power to bind to MMP14 (Sakamoto et al., 2010).
When FIH-1 is bound to MMP14 instead of BAX, the cell will be
less resistant to death (Figure 2).

Figure 2. With low MMP14 expression, FIH-1 (red) is bound to
BAX (orange) in the mitochondria. When FIH-1 and BAX are bound,
this prevents cell-death. On the other hand, increasing the expression
of MMP14 on the cell surface causes FIH-1 to bind to MMP14,
instead of BAX. When FIH-1 is not bound to BAX it will lead to celldeath.

Significance of this Study
Because cancer is a prevalent issue within society, this finding may
help advance therapeutic cancer strategies in the right direction.
Certain cancer cells may be manipulated to express more matrix
metalloproteinases, which may have the potential to trigger
apoptosis. This research finding helps with understanding how
MMP14, FIH-1, and BAX are intertwined, and how they can be used
to manipulate apoptotic sensitivity in cancer cells. Ideally, further
studies would need to be done.
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